Hoffbrand Av

411 total citations
28 papers, 350 citations indexed

About

Hoffbrand Av is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Hoffbrand Av has authored 28 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Hoffbrand Av's work include Chronic Lymphocytic Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (3 papers) and Folate and B Vitamins Research (3 papers). Hoffbrand Av is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (3 papers) and Folate and B Vitamins Research (3 papers). Hoffbrand Av collaborates with scholars based in United Kingdom. Hoffbrand Av's co-authors include K. Ganeshaguru, Joyce E. Reittie, T. J. Peters, G Jánossy, Emilio Porfiri, G. E. Francis, Dario Campana, H Jani, Dimitrios Politis and Elaine Coustan‐Smith and has published in prestigious journals such as PubMed.

In The Last Decade

Hoffbrand Av

28 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hoffbrand Av United Kingdom 12 174 151 93 76 62 28 350
P Beris Switzerland 11 328 1.9× 117 0.8× 81 0.9× 57 0.8× 53 0.9× 27 424
AK Burnett United Kingdom 9 346 2.0× 204 1.4× 64 0.7× 33 0.4× 77 1.2× 16 469
Stefania Ciolli Italy 12 247 1.4× 128 0.8× 124 1.3× 46 0.6× 78 1.3× 40 399
Z. T. Maung United Kingdom 9 140 0.8× 52 0.3× 145 1.6× 50 0.7× 89 1.4× 13 318
Spurr Cl United States 8 132 0.8× 70 0.5× 74 0.8× 31 0.4× 111 1.8× 20 326
Cheryl Boyd United States 6 350 2.0× 174 1.2× 37 0.4× 47 0.6× 83 1.3× 6 399
F. C. de Waal Netherlands 9 124 0.7× 39 0.3× 130 1.4× 43 0.6× 157 2.5× 23 332
J Bury Belgium 11 157 0.9× 47 0.3× 64 0.7× 24 0.3× 115 1.9× 27 310
J Voglová Czechia 10 210 1.2× 181 1.2× 39 0.4× 28 0.4× 34 0.5× 33 303
P Gravett United Kingdom 7 272 1.6× 43 0.3× 89 1.0× 90 1.2× 29 0.5× 14 357

Countries citing papers authored by Hoffbrand Av

Since Specialization
Citations

This map shows the geographic impact of Hoffbrand Av's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoffbrand Av with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoffbrand Av more than expected).

Fields of papers citing papers by Hoffbrand Av

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoffbrand Av. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoffbrand Av. The network helps show where Hoffbrand Av may publish in the future.

Co-authorship network of co-authors of Hoffbrand Av

This figure shows the co-authorship network connecting the top 25 collaborators of Hoffbrand Av. A scholar is included among the top collaborators of Hoffbrand Av based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoffbrand Av. Hoffbrand Av is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Av, Hoffbrand. (2005). Oral iron chelators in the treatment of hematologic diseases.. PubMed. 3(7). 536–8. 2 indexed citations
2.
Av, Hoffbrand. (1996). Oral iron chelation.. PubMed. 33(1). 1–8. 34 indexed citations
3.
Foroni, Letizia, et al.. (1995). Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes.. PubMed. 9(5). 821–5. 27 indexed citations
4.
Amlot, P L, et al.. (1994). Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutation.. PubMed. 8(7). 1139–45. 23 indexed citations
5.
Av, Hoffbrand, et al.. (1994). Inactivation of calcium ion-regulating inositol polyphosphate second messengers is impaired in subpopulations of human leukemia cells.. PubMed. 8(10). 1718–25. 11 indexed citations
6.
Av, Hoffbrand, et al.. (1993). Autocrine and paracrine growth loops in chronic lymphocytic leukemia.. PubMed. 30(4). 306–17. 51 indexed citations
7.
Sissolak, Gerhard, et al.. (1993). Interferon-alpha inducible 2'-5' oligoadenylate synthetase transcripts in lymphoid and myeloid leukemias.. PubMed. 7(5). 712–6. 6 indexed citations
8.
Hall, Belinda S., et al.. (1989). An endogenous inhibitor of the protein tyrosine kinase activity of normal and malignant human lymphoid cells.. PubMed. 4(10). 1225–31. 1 indexed citations
9.
Wonke, B., et al.. (1989). Cardiac complications in homozygous beta-thalassemia.. PubMed. 309. 51–6. 2 indexed citations
10.
Av, Hoffbrand, et al.. (1989). Spontaneous splenic rupture in myelodysplastic syndrome.. PubMed. 42(4). 410–1. 4 indexed citations
11.
Gj, Kontoghiorghes, et al.. (1989). Prospects for effective oral iron chelation therapy in man with 1,2-dimethyl-3-hydroxypyrid-4-one and other alpha-ketohydroxypyridines.. PubMed. 309. 107–14. 12 indexed citations
12.
Porfiri, Emilio, et al.. (1988). Granulocytic differentiation of HL60 human promyelocytic leukemia cells is preceded by a reduction in levels of inositol lipid-derived second messengers.. PubMed. 16(7). 641–6. 13 indexed citations
13.
Campana, Dario, Hoffbrand Av, G Jánossy, et al.. (1987). Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.. PubMed. 1(11). 757–61. 50 indexed citations
14.
Francis, G. E., et al.. (1984). The identification of mixed granulocytic-erythrocytic colonies in vitro.. PubMed. 12(7). 535–8. 16 indexed citations
15.
Av, Hoffbrand, et al.. (1982). Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.. PubMed. 18(7). 347–53. 17 indexed citations
16.
Francis, G. E., et al.. (1981). Bone marrow endogenous colony stimulating factor(s): relation to granulopoiesis in vivo.. PubMed. 9(4). 332–45. 8 indexed citations
17.
Francis, G. E., et al.. (1981). Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells.. PubMed. 1(2). 124–39. 14 indexed citations
18.
Av, Hoffbrand. (1971). Recent advances in the megaloblastic anaemias.. PubMed. 25(6). 257–62. 1 indexed citations
19.
Av, Hoffbrand & T. J. Peters. (1970). Recent advances in knowledge of clinical and biochemical aspects of folate.. PubMed. 100(46). 1954–60. 20 indexed citations
20.
Av, Hoffbrand & T. J. Peters. (1969). Subcellular localization of folate conjugase in guinea-pig intestinal mucosa.. PubMed. 202(1). 40P–40P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026